Biomarker: HBcrAg (Hepatitis B core related antigen)

A serological marker correlated with cccDNA for improved monitoring of HBV patients under treatment

The most common used treatment for patients with chronic HBV infection are nucleos(t)ide analogues (NUC’s). This treatment has overcome the problem of side-efects and genotype-dependency that is observed in the treatment with pegylated-interferon. However, where treatment with interferon is finite, this is not the case with NUC´s.

Potential stopping rules for treatment are therefore highly wanted by both the clinicians and the patients. Another difficulty is that the active replication of HBV can only be determined by an invasive and non-standardized way: measurement of covalently closed circular DNA (cccDNA) which is very dependent on the technology used and this from a liver biopsy which is an invasive sample to collect.

Patients today are monitored with diferent tools such as ALT, HBV DNA and (quantifcation of) hepatitis B surface antigen. HBcrAg can serve to measure the replication of the virus and is today already used in Japan in routine monitoring to identify patients where treatment can be discontinued.1

References:

  1. Ohishi W, et al. Treatment of chronic hepatitis B with nucleos(t)ide analogues. Hepatol. Res. 2012 Mar; 42(3): 219-25.

Lumipulse® G HBcrAg

Our Lumipulse G HBcrAg immunoreaction cartridges set for Research Use Only (not for use in diagnostic procedures) with the LUMIPULSE® G System for the quantitative detection of hepatitis B virus core-related antigen in serum or plasma.

Read more here

Welcome to Fujirebio

Please indicate from which location you are connecting:

Once you have made this selection we will show you only the content that is relevant for your country. You can change this setting any time by clicking on the flag in the top toolbar of our website and choosing another country.

More than 50 years of pioneering expertise in IVD

Image

We are a global leader in the field of high quality in vitro diagnostics (IVD) testing. We have more than 50 years’ accumulated experience in the conception, development, production and worldwide commercialization of robust IVD products. Our IVD product lines span the range from specialized manual and automated testing to fully automated routine clinical laboratory testing solutions.

CLOSE

You can change the country filter for contents in our website. You will then see local contact information and other information available for that country. Please choose your country in the list below: